Ekso Bionics (EKSO)
(Delayed Data from NSDQ)
$1.00 USD
-0.05 (-4.76%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.03 +0.03 (3.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EKSO 1.00 -0.05(-4.76%)
Will EKSO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EKSO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EKSO
Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates
Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices
EKSO: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Ekso Bionics (EKSO) Rating Upgrade to Buy
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Here's Why Ekso Bionics (EKSO) Is a Great 'Buy the Bottom' Stock Now
Other News for EKSO
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Crude Oil Down 1%; Procter & Gamble Shares Fall After Q4 Results
Lake Street Sticks to Its Buy Rating for EKSO BIONICS (EKSO)
Why Is Imunon (IMNN) Stock Up 259% Today?
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?